Biomarkers predictive of cancer cell response to ML329 or a derivative thereof
US-12560609-B2 · Feb 24, 2026 · US
Fisher David is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Fisher David |
| Total patents | 16 |
| First publication | May 2, 2019 |
| Latest publication | Feb 24, 2026 |
Publications ranked by popularity score, then publication date.
US-12560609-B2 · Feb 24, 2026 · US
US-2025024847-A1 · Jan 23, 2025 · US
US-2024156117-A1 · May 16, 2024 · US
US-2024090389-A1 · Mar 21, 2024 · US
US-2024092719-A1 · Mar 21, 2024 · US
US-2024008501-A1 · Jan 11, 2024 · US
US-11827591-B2 · Nov 28, 2023 · US
US-2023072790-A1 · Mar 9, 2023 · US
US-2022135510-A1 · May 5, 2022 · US
US-2022128562-A1 · Apr 28, 2022 · US
Latest publications not already listed above.
US-11160339-B2 · Nov 2, 2021 · US
US-2021149649-A1 · May 20, 2021 · US
US-2021140604-A1 · May 13, 2021 · US
US-10884719-B2 · Jan 5, 2021 · US
US-2020397012-A1 · Dec 24, 2020 · US
US-2019129698-A1 · May 2, 2019 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Apeel Tech Inc | 9 |
| Synchrony Bank | 3 |
| Knoll Inc | 2 |
| Dana Farber Cancer Inst Inc | 2 |
| Massachusetts Gen Hospital | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A23B7/16 | 6 |
| A23B7/154 | 5 |
| A23B2/758 | 4 |
| C07D201/12 | 3 |
| C08J11/10 | 3 |